Treatment paradigm for recurrent endometriosis shifts from surgery to medication koreabiomed.com
Dienogest (DNG) is widely used to manage endometriosis-associated pain; however, long-term data comparing low and standard doses are limited. Therefore, this study aimed to evaluate the efficacy and safety of …
Endometriosis is an estrogen-dependent disease, and hormonal treatment is the most common treatment. Both deep infiltrating endometriosis (DIE) and ovarian endometrioma (OV) are characterized by dense surrounding fibrotic tissue. However, …
Background/Objectives: Oxidative stress is a critical factor in the development and progression of endometriosis. Granulosa cells, which reside near oocytes in follicles, exhibit steroidogenic activity, and, consequently, influence oocyte quality. …
Steroid receptor coactivators (SRCs) are master regulators of nuclear receptor signaling and play essential roles in female reproductive physiology. By integrating steroid hormone signaling with growth factors and metabolic pathways, …
ASCO Reading Room | Here's How the Treatment Landscape for Gynecologic Cancers Is About to Change MedPage Today
French medical technology company EDAP secures €36 million credit facility from EIB to advance prostate cancer and endometriosis non-invasive treatment The European Sting
Cyclana Bio raises £5m to advance endometriosis treatment Med-Tech Insights
‘It’s not just cramps’: Women forced to seek endometriosis treatment privately amid long NHS waiting times Suffolk News
Endometriosis, a common gynecological disease, leads to dysmenorrhea and infertility. EMT process was closely related to the pathology of endometriosis. More therapies were required to be explored for endometriosis management. …